These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10987632)

  • 41. Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality.
    Durna EM; Wren BG; Heller GZ; Leader LR; Sjoblom P; Eden JA
    Med J Aust; 2002 Oct; 177(7):347-51. PubMed ID: 12358575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists.
    Mills PK; Beeson WL; Phillips RL; Fraser GE
    Cancer; 1989 Aug; 64(3):591-7. PubMed ID: 2743253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients.
    Jernström H; Frenander J; Fernö M; Olsson H
    Br J Cancer; 1999 Jul; 80(9):1453-8. PubMed ID: 10424750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
    Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy.
    Stahlberg C; Pedersen AT; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Møller S; Rank F; Ottesen B; Lynge E
    Br J Cancer; 2004 Aug; 91(4):644-50. PubMed ID: 15238982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study.
    Jiang Y; Xie Q; Chen R
    Clin Breast Cancer; 2022 Feb; 22(2):e206-e213. PubMed ID: 34548240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy.
    Hedblad B; Merlo J; Manjer J; Engström G; Berglund G; Janzon L
    Scand J Public Health; 2002; 30(1):12-9. PubMed ID: 11928828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women.
    Calle EE; Miracle-McMahill HL; Thun MJ; Heath CW
    J Natl Cancer Inst; 1995 Apr; 87(7):517-23. PubMed ID: 7707438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women.
    Cerne JZ; Ferk P; Leskosek B; Gersak K
    Climacteric; 2011 Aug; 14(4):458-63. PubMed ID: 21294673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.
    Brett KM; Madans JH
    Am J Epidemiol; 1997 Mar; 145(6):536-45. PubMed ID: 9063344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.
    Espié M; Mares P; de Reilhac P; Chevallier T; Daurès JP
    Gynecol Endocrinol; 2006 Aug; 22(8):423-31. PubMed ID: 17012103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual effects of weight and weight gain on breast cancer risk.
    Huang Z; Hankinson SE; Colditz GA; Stampfer MJ; Hunter DJ; Manson JE; Hennekens CH; Rosner B; Speizer FE; Willett WC
    JAMA; 1997 Nov; 278(17):1407-11. PubMed ID: 9355998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations.
    Schneider C; Jick SS; Meier CR
    Climacteric; 2009 Dec; 12(6):514-24. PubMed ID: 19905903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.
    Rodriguez C; Patel AV; Calle EE; Jacob EJ; Thun MJ
    JAMA; 2001 Mar; 285(11):1460-5. PubMed ID: 11255422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
    Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women.
    Colditz GA; Stampfer MJ; Willett WC; Hennekens CH; Rosner B; Speizer FE
    JAMA; 1990 Nov; 264(20):2648-53. PubMed ID: 2232041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.